Institute for the Care of Mother and Child, Prague, Czech Republic Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2019
NCT03899597
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Institute for the Care of Mother and Child, Prague, Czech Republic

Active Ingredients

Drugs in Phase 4 Trials (1)

hyaluronic acid (1 trial)

Drugs in Other Trials (1)

oxytocin (syntocinon) (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2